Skip to main content
OpenTrials
Completed

NCT Number: NCT02864589

Internet-based Behaviour Therapy for Tourette's Disorder and Chronic Tic Disorder

The purpose of this study is to evaluate the feasibility and acceptability of two different modalities of therapist-guided Internet-delivered behaviour therapy (IBT) for children and adolescents (7-17 years) with Tourette's Disorder (TD) or Persistent (Chronic) Motor or Vocal Tic Disorder (PTD).

Completed

Looking for future studies?

Notify Me

Key information

About this study

The primary objective of this study is to evaluate the feasibility and acceptability of two different modalities of therapist-guided Internet-delivered behaviour therapy (IBT) for children and adolescents (7-17 years) with Tourette's Disorder (TD) or Persistent (Chronic) Motor or Vocal Tic Disorder (PTD). The two modalities of IBT are habit reversal training (HRT) and exposure and response prevention (ERP). Secondary objectives are to evaluate whether IBT can decrease tic frequency and tic-related impairment, and, as both HRT and ERP have been proven efficacious in treating TD/PTD face-to-face, are any of the two treatments better suited to be delivered via the internet?

The design of the study is a randomized-controlled trial with 20 participants. Participants will be stratified by ADHD/ADD status.

The treatment duration is 10 weeks.

Feasibility and acceptability will be assumed if:

  • The two treatments can be successfully adapted to a therapist guided internet-delivered format (technical feasibility)
  • Patients/parents are willing to try the offered treatment modalities
  • Participants complete the active parts of the treatment
  • Referrers are open to the idea of internet-delivered treatment for TD or PTD
  • We can recruit sufficient numbers of patients for a fully powered efficacy trial

Regarding the secondary objective, the primary outcome is tic severity measured by the Yale Global Tic Severity Scale (YGTSS). Participants will be assessed directly after treatment (post), and at 3, 6 and 12 months after treatment. Assessments at post-treatment and 3 month follow up will be performed by assessors blinded to the treatment condition. After 3 months, we will naturalistically follow up patients up to 12 months after the end of treatment. Data collection will finish 12 months after treatment.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Fulfill DSM-5 diagnostic criteria for Tourette's Disorder or Persistent (Chronic) Motor or Vocal Tic Disorder (PTD).
  • >15 (TD) or >10 (PTD) on Yale Global Tic Severity Scale (Impairment not included).
  • Both child and parent are able to read and communicate in Swedish.
  • Regular access to a computer and the Internet.
  • Parent availability to support their child throughout the treatment.

Exclusion criteria

  • Acute psychiatric problems such as severe depression, suicidal risk, substance abuse or another psychiatric disorder that could interfere with treatment.
  • Lifetime history of global learning disability, pervasive developmental disorder, psychosis, bipolar disorder or organic brain disorder.
  • Severe tics causing immediate risk to the patients or others and requiring urgent medical attention.
  • Previous behavioural therapy (HRT or ERP), minimum 8 sessions with qualified therapist, within the last 12 months prior to assessment.
  • Simultaneous psychological treatment for tic disorder.
  • Initiation or adjustment of any psychotropic medication for tics within the last 6 weeks prior to assessment.

Treatment and study plan

Internet-delivered habit reversal training

Behavioral

The I-HRT group will receive a 10-week therapist-guided, parent-assisted, Internet-delivered behavioural treatment. The treatment is based on existing literature on habit reversal training (i.e. Woods, D.W. (2008). Managing Tourette syndrome: A behavioral intervention for children and adults therapist guide. OUP, USA.) with added interactive features as videos and illustrations. In short, the participants practice to become more aware of their tics and inhibit them by performing competing responses (movements). The treatment is therapist guided: the participants have regular (up to 5 days a week) contact with a personally assigned therapist via written text in the platform and occasionally via the telephone. The children and parents have separate logins and access partly different content.

Other names: HRT, HR

Internet-delivered exposure and response prevention

Behavioral

The I-ERP group receives a 10-week therapist-guided, parent-assisted, Internet-delivered behavioural treatment. The treatment is based on existing literature on exposure and response prevention (i.e. Verdellen, C. et al. (2011). Tics: Therapist manual & workbook for children. Boom, Amsterd.) with added interactive features as videos and illustrations. In short, the participants practice to suppress their tics for longer and longer times, at the same time as premonitory urges are intentionally provoked. The treatment is therapist-guided: the children and parents have regular (up to 5 days a week) contact with a personally assigned therapist via written text in the platform and occasionally via the telephone. The children and parents have separate logins and access partly different content.

Other names: ERP

Primary outcomes

  1. Yale Global Tic Severity Scale (YGTSS)

    Time frame: Week 0; week 10; 3 months follow up; 6 months follow up; 12 months follow up

    Change in tic severity (motor and/or vocal tics) from week 0 (pre treatment) to week 10 (post treatment), 3 months follow up (after post treatment), 6 months follow up and 12 months follow up.

Secondary outcomes

  1. Clinical Global Impression - Severity (CGI-S)

    Time frame: Week 0; week 10; 3 months follow up; 6 months follow up; 12 months follow up

  2. Clinical Global Impression - Improvement (CGI-I)

    Time frame: Week 10; 3 months follow up; 6 months follow up; 12 months follow up

  3. Children's Global Assessment Scale (C-GAS)

    Time frame: Week 0; week 10; 3 months follow up; 6 months follow up; 12 months follow up

  4. Parent Tic Questionnaire (PTQ)

    Time frame: Week 0; week 5; week 10; 3 months follow up; 6 months follow up; 12 months follow up

  5. Premonitory urge for Tics Scale (PUTS)

    Time frame: Week 0; week 5; week 10; 3 months follow up; 6 months follow up; 12 months follow up

  6. Gilles de la Tourette Syndrome Quality of Life Scale (GTS-QOL).

    Time frame: Week 0; week 10; 3 months follow up; 6 months follow up; 12 months follow up

  7. Obsessive-Compulsive Inventory - Child version (OCI-CV).

    Time frame: Week 0; week 10; 3 months follow up; 6 months follow up; 12 months follow up

  8. Children's Depression Inventory - Short version (CDI-S), with additional suicidality item

    Time frame: Week 0; week 5; week 10; 3 months follow up; 6 months follow up; 12 months follow up

  9. Mood and Feeling Questionnaire - Short version (MFQ)

    Time frame: Week 0; week 5; week 10; 3 months follow up; 6 months follow up; 12 months follow up

  10. Education, Work and Social Adjustment Scale - Child version (EWSAS-C)

    Time frame: Week 0; week 10; 3 months follow up; 6 months follow up; 12 months follow up

  11. Education, Work and Social Adjustment Scale - Parent version (EWSAS-P)

    Time frame: Week 0; week 10; 3 months follow up; 6 months follow up; 12 months follow up

  12. Treatment credibility scale

    Time frame: Week 3

  13. Treatment satisfaction scale

    Time frame: Week 10

  14. Safety Monitoring Uniform Report Form (SMURF)

    Time frame: Week 5; week 10

  15. Internet Intervention Patient Adherence Scale (iiPAS)

    Time frame: Week 5; week 10

  16. Parental strategy scale

    Time frame: Week 10

Sponsors and collaborators

Lead sponsor

Karolinska Institutet

Other

Registry information

Official study title

Internet-based Behaviour Therapy for Tourette's Disorder and Chronic Tic Disorder: A Feasibility Study

Important dates

Study start
2016
Primary completion
2018
Study completion
2018
First posted
Aug 12, 2016
Registry last updated
Mar 6, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.